Live GMP
Aureate Tradde Ltd GMP ₹0 Hexagon Nutrition Ltd GMP ₹3+6.67% Genxai Analytics Ltd GMP ₹0 Vahh Chemicals Ltd GMP ₹0 CMR Green Technologies Ltd GMP ₹0 Merritronix Ltd GMP ₹93+62.42% Liotech Industries Ltd. GMP ₹0
Vaidya Sane Ayurved Laboratories Ltd. Logo

Vaidya Sane Ayurved Laboratories Ltd. IPO

Closed Fixed Price IPO NSE SME Fresh Capital
← Back to GMP
Issue Price ₹73
GMP
Lot Size 1,600
Face Value ₹10
Issue Size 2,771,200 shares (aggregating up to ₹20 Cr)
Subscription

IPO Timeline

Open Date10-Feb-22
Close Date15-Feb-22
Allotment18-Feb-22
Refund Initiation21-Feb-22
Demat Credit22-Feb-22
UPI Mandate Deadline15-Feb-22
Listing Date23-Feb-22

Category-wise Subscription

Shares offered, bid & amount
CategorySub (x)OfferedBid ForAmt (Cr)*
NII (HNI) 1,315,200 (47%) ₹960 Cr
Retail 1,315,200 (47%) ₹960 Cr
Market Maker 140,800 (5%) ₹10 Cr
Σ  Total2,771,200 (100%)₹20,230 Cr

Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.

Issue Details

Issue Price / Price Band₹73
Face Value₹10
Lot Size1,600 shares
Issue Size2,771,200 shares (aggregating up to ₹20 Cr)
Issue TypeFixed Price IPO
Listing ExchangeNSE SME
Sale TypeFresh Capital
Script Code
Net Offer to Public2,630,400 shares (aggregating up to ₹19 Cr)
Amount InCrore
Stock Price History · NSE
Loading chart data...
H
L
O
Yahoo Finance · Live

Minimum Investment (Lot-wise)

CategoryLotsSharesAmount (₹)
Retail (Min)11,600₹116,800
Retail (Max)1320,800₹1,518,400
S-HNI (Min)1422,400₹1,635,200
B-HNI (Min)67107,200₹7,825,600
Retail1 lot(s)1,600 shares₹116,800
S-HNI2 lot(s)3,200 shares₹233,600

Shareholding Pattern

Pre-Issue Shareholding7,742,250 shares%
Post-Issue Shareholding10,513,450 shares%
Reserved for Market Maker140,800 shares (aggregating up to ₹1 Cr)

Financial Statements Amount In Crore

Metric 30-Sep-21 31-Mar-21 31-Mar-20
Revenue 32 52 75
Profit After Tax 1 2 -1
Total Assets 26 26 29

Valuation & Key Ratios

ROE
ROCE
RONW
PAT Margin
EBITDA Margin
Debt/Equity
P/BV
Pre EPS
Post EPS
Pre P/E28
Post P/E

Grey Market Premium (GMP)

Current GMP

GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.

Objects of the Issue

  • 1 Expenses on Marketing and Branding – 16.00
  • 2 General Corporate Purposes – 3.73
  • 3 Issue Related Expenses – 0.50

Company Overview

Madhavbaug is a medical service institution engaged in the treatment of chronic ailments like cardiac disease, diabetes, hypertension, and obesity by combining modern technology with the traditional Ayurveda practices. It uses non-invasive, multidisciplinary, and innovative therapies for treating chronic ailments. The company mainly offers treatment for (i) Health disease reversal, (ii) Diabetes Reversal, (iii) BP Management, (iv) Obesity management, Knee pain relief.

As of November 30, 2021, the company operates 274 clinics across Maharashtra, Madhya Pradesh, Gujarat, Uttar Pradesh, Goa, Karnataka, Delhi, and Chhattisgarh. Out of these 52 are company-owned and 222 are franchise clinics. The company also operates two cardiac prevention and rehabilitation hospitals in Khopoli and Nagpur respectively.

The company offers several wellness products through their online portal Madhavbaug Wellness, and has an online app called MIB Pulse App which helps heart patients.

Competitive Strengths:

  • The amalgamation of modern and ancient methods for curing diseases
  • Affordable and non-invasive treatments
  • Experienced leadership and well-trained team
  • In-house IT platform for operational efficiency and innovations
  • MIS system for better management

Company Information

AddressFl. 5, 1047, Shriram Bhawan, Shukrawar Peth, Pune, Maharashtra, 411002